Bone & Joint Health Supplements Market Size & Share 2024 to 2032

Bone & Joint Health Supplements Market Size

Bone & Joint Health Supplements Market size was valued to be around USD 13.6 billion in 2023 and is anticipated to grow at a CAGR of 7.5% from 2024 to 2032. The increasing ageing population, rising prevalence of bone-related disorders, and growing awareness & demand for dietary supplements are the significant contributors to the considerable gains of this industry.

For instance, according to the Consumer Survey on Dietary Supplements 2022 conducted by Council for Responsible Nutrition, nearly 75% of Americans use dietary supplements among which majority of users are regular users of dietary supplements including bone & joint supplements. This surge in consumption of nutraceutical products such as dietary supplements and a heightened emphasis on preventive healthcare contribute significantly to the escalating demand for these products.
 

Bone and joint health supplements are dietary products formulated to support and promote the well-being of the skeletal system, particularly bones and joints. These supplements typically contain a combination of vitamins, minerals, and other bioactive compounds that help to contribute to bone density, joint flexibility, and overall musculoskeletal health.
 

COVID-19 Impact

The COVID-19 pandemic has catalysed a positive shift in consumer attitudes towards health and wellness, thereby influencing the bone and joint health supplement market. The pandemic has spurred in home-based fitness activities, as lockdowns prompted people to seek alternative ways to stay active.
 

Bone & Joint Health Supplements Market Trends 

• As the global population ages, the prevalence of age-related health issues, including bone and joint disorders increases. This population is more susceptible to conditions such as osteoporosis, arthritis, and general joint stiffness. Also, the awareness pertaining to the  benefits of bone and joint health supplements has grown, leading to an increased adoption of products containing ingredients such as calcium, vitamin D, vitamin K, glucosamine, collagen supplement, and others.
   
• Additionally, the market has witnessed a surge in innovative delivery formulations beyond traditional tablets and capsules. Gummies, powders, and liquid formulations are becoming more popular, offering consumers diverse options for supplementation.
   

Bone & Joint Health Supplements Market Analysis 

Based on product, the market is classified as vitamins & minerals, collagen, glucosamine-chondroitin, omega-3 fatty acid, and other products. In 2023, vitamins & minerals segment accounted for a significant market share of 50.1%.
 

• Vitamins & minerals such as calcium, vitamin D, vitamin K, magnesium, phosphorus, and others play are fundamental nutrients in bone formation, mineralization, and overall bone health. Their importance in maintaining strong bones and joints positions them as foundational components of bone health supplements.
   
• The vitamin & mineral products are easily accessible and affordable, making them more widely available to a diverse consumer base. Additionally, the advantages such as improved bone density, enhanced joint function, inflammation reduction, and a lowered risk of fractures.
   

Based on form, the global bone & joint health supplements market is segmented into capsules & tablets, powders, liquids, and other forms. The capsules & tablets segment dominated the market and is expected to register progrssion of 8.1% by 2032.
 

• Capsules and tablets generally have a longer shelf life compared to other dosage forms. It reduces the likelihood of product degradation over time and allows for extended storage. In addition to this, the factors such as convenience, ease of consumption, accuracy in dosage, stability, manufacturing efficiency, and positive consumer perception.
   

Based on consumer, the market is divided into geriatric population, adults, pregnant women, children, and infants. The geriatric population segment is expected to reach USD 8.9 billion by 2032.
 

• Aging is often accompanied by a higher prevalence of bone and joint health issues such as osteoporosis, arthritis, and general joint stiffness. Also, bone and joint health supplements are seen as proactive measures to prevent or alleviate conditions associated with aging.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on distribution channel, the global bone & joint health supplements market is categorized into pharmacies, brick & mortar, e-commerce, and other distribution channels. The pharmacies segment is anticipated to witness expansion at 7.9% during the analysis period to reach USD 10 billion by 2032.
 

• Pharmacies typically offer a wide range of healthcare products, including various bone and joint health supplements. This diversity allows consumers to choose from different brands, formulations, and price points, meeting individual preferences and needs.
   
• Furthermore, the presence of licensed pharmacists and adherence to regulatory standards contribute to the credibility of products available in pharmacies, assuring consumers safety.
   

The North America bone & joint health supplements market accounted for USD 5.2 billion in 2023.
 

• North America comprises significant aging population. With the growing geriatric population, there is a higher prevalence of bone and joint health issues such as osteoporosis and arthritis.
   
• Moreover, few of the other factors that boosts the regional gains includes well-established healthcare systems, presence of key market players, consumer awareness and increased adoption of supplements.
   

Bone & Joint Health Supplements Market Share 

The bone & joint health supplements industry is characterized by a diverse array of players engaged in strategic initiatives to strengthen their market position and cater to the evolving needs of consumers.
 

Bone & Joint Health Supplements Market Companies

Prominent players operating in the bone & joint health supplements industry is as mentioned below:

• Bayer AG
• Amway
• BASF SE
• Vita Life Sciences Ltd
• Glanbia plc
• Arazo Nutrition
• Reckitt Benckiser Group plc
• Nature's Bounty, Inc.
• NOW Foods
• GNC Holdings, LLC
   

Bone & Joint Health Supplements Industry News: 

• In September 2023, Voltaren launched its Joint Comfort & Movement Daily Supplement and Joint Health & Bone Strength Dietary Supplement. This strategy is expected to add value to its existing business portfolio and generate revenue from its sales.
   
• In March 2023, FlexAgain revealed its plans to introduce joint supplements on popular third-party marketplaces such as Amazon. The decision to launch on these platforms was driven by increasing demand for dietary supplements and growing predominance of e-commerce, thereby strengthening its market position.
   

The bone & joint health supplements market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product, 2018 – 2032 (USD Million)

• Vitamins & minerals
• Collagen
• Glucosamine-chondroitin
• Omega-3 fatty acid
• Other products

By Form, 2018 – 2032 (USD Million)

• Capsules & tablets
• Powders
• Liquids
• Other forms

By Consumer, 2018 – 2032 (USD Million)

• Geriatric population
• Adults
• Pregnant women
• Children
• Infants

By Distribution Channel, 2018 – 2032 (USD Million)

• Pharmacies
• E-commerce
• Brick & mortar
• Other distribution channels

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa